Home » Newsletters » BioWorld Science

BioWorld Science

June 28, 2000

View Archived Issues

Estrogen fails to alter cognition, mood or cerebral blood flow in Alzheimer's patients

Disulfiram plus buprenorphine curbs cocaine use in dual opioid/cocaine-dependent subjects

Aventis and Millennium establish alliance for antiinflammatory drugs and drug discovery technologies

Lorus Therapeutics reports strong meta-analysis results for Virulizin, prepares for phase III trials

Celsion submits IND for phase II trials of BPH treatment

COX-2 identified as new therapeutic target for type 1 diabetes

FDA completes initial review of BLA for Campath

StressGen's HspE7 advances to phase III trials in anal dysplasia

Cholinergic agonist for Sjogren's syndrome introduced in U.S.

Takeda's angiogenesis inhibitor TNP-470 shows additional potential in rheumatoid arthritis

ENDO 2000 news: U.S. researchers characterize potent new antiprogestational agent

Further details on pharmacological profile of FE-200486 presented at ENDO 2000

SM-31900 emerges as a promising therapeutic for stroke

Endogenous pulsatile GH secretion, plasma IGF-I levels stimulated by low-dose NN-703

JTT-608 stimulates GLP-1 secretion from the intestine, similar to glucose

AndroGel now available in U.S. to treat men with hypogonadism

Apoptosis-inducing small molecule targeting Bcl-2 recently identified

Insmed completes acquisition of Celtrix; now has two product candidates in phase II

New Pfizer compounds with selectivity for certain MMPs and TACE

Compounds with urethra-selective contractile activity in development for urinary incontinence

Roche presents 4-aroylpiperidines active as chemokine receptor antagonists

BASF joins in search for therapeutically useful PARP inhibitors

Novel kininogen-derived antiangiogenic peptides emerge from joint research program

Human parvovirus-containing vaccines for rheumatoid arthritis

Riluzole + alpha-tocopherol delays progression of ALS more frequently than riluzole alone

Use of seratrodast for COPD supported by clinical results

Baxter completes acquisition of North American Vaccine

United Therapeutics discontinues UT-77 development project

Cytogen seeks European approval of ProstaScint

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...